<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Loss of imprinting (LOI) of the insulin-like growth factor 2 (IGF2) and H19 genes on human chromosome 11 has been found not only in <z:e sem="disease" ids="C1368871" disease_type="Neoplastic Process" abbrv="">childhood tumors</z:e> but also in common adult <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> including <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Recently, a transcript called LIT1 (long QT intronic transcript 1) has been identified within the KvLQT1 locus on chromosome 11 </plain></SENT>
<SENT sid="2" pm="."><plain>LIT1 is expressed preferentially from the paternal allele and is transcribed in most human tissues </plain></SENT>
<SENT sid="3" pm="."><plain>LOI of LIT1 was found in a considerable number of <z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith-Wiedemann syndrome</z:e> (BWS) patients, suggesting that it is associated with the etiology of BWS </plain></SENT>
<SENT sid="4" pm="."><plain>Since LOI of IGF2 was observed in association with overexpression of IGF2 in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> in our previous study, we examined the status of <z:mp ids='MP_0003121'>genomic imprinting</z:mp> of LIT1 and H19 in comparison with IGF2 in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>We examined 44 surgically dissected <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> tissues </plain></SENT>
<SENT sid="6" pm="."><plain>Ten of them represented informative cases for LIT1 </plain></SENT>
<SENT sid="7" pm="."><plain>None of these patients exhibited loss of heterozygosity (LOH) of LIT1, and LOI of LIT1 was observed in 4 of the 10 (40%) informative patients, but not in non-cancerous tissues </plain></SENT>
<SENT sid="8" pm="."><plain>Neither LOH nor LOI of H19 was observed </plain></SENT>
<SENT sid="9" pm="."><plain>LOI of IGF2 was observed in 4 of 18 (22%) informative patients </plain></SENT>
<SENT sid="10" pm="."><plain>These results suggest that LOI of LIT1 is frequently observed in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> and may be a useful marker for diagnosis of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
</text></document>